MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer

Gastroenterology

Volumn 133, Issue 2, 2007, Pages 647-658

  Meng, Fanyin ^a,b   Henson, Roger ^a   Wehbe Janek, Hania ^a   Ghoshal, Kalpana ^b   Jacob, Samson T ^b   Patel, Tushar ^a,b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MICRORNA; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 34547524771     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.05.022     Document Type: Article

References (30)

1. El Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
2. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339-346
3. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
4. Thorgeirsson S.S., Lee J.S., and Grisham J.W. Functional genomics of hepatocellular carcinoma. Hepatology 43 (2006) S145-S150
5. Calin G.A., and Croce C.M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66 (2006) 7390-7394
6. Esquela-Kerscher A., and Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6 (2006) 259-269
7. McManus M.T. MicroRNAs and cancer. Semin Cancer Biol 13 (2003) 253-258
8. Kutay H., Bai S., Datta J., Motiwala T., Pogribny I., Frankel W., Jacob S.T., and Ghoshal K. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 15 (2006) 671-678
9. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., and Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25 (2006) 2537-2545
10. Meng F., Henson R., Lang M., Wehbe H., Maheshwari S., Mendell J.T., Jiang J., Schmittgen T.D., and Patel T. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130 (2006) 2113-2129
11. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374-378
12. Meng F., Yamagiwa Y., Ueno Y., and Patel T. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes. J Hepatol 44 (2006) 1055-1065
13. Park J., Tadlock L., Gores G.J., and Patel T. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology 30 (1999) 1128-1133
14. Chan J.A., Krichevsky A.M., and Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65 (2005) 6029-6033
15. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., and Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103 (2006) 2257-2261
16. Kim R.H., and Mak T.W. Tumours and tremors: how PTEN regulation underlies both. Br J Cancer 94 (2006) 620-624
17. Gautam A., Li Z.R., and Bepler G. RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene 22 (2003) 2135-2142
18. Park M.J., Kim M.S., Park I.C., Kang H.S., Yoo H., Park S.H., Rhee C.H., Hong S.I., and Lee S.H. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res 62 (2002) 6318-6322
19. Akahane T., Akahane M., Shah A., Connor C.M., and Thorgeirsson U.P. TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. Exp Cell Res 301 (2004) 158-167
20. Horie Y., Suzuki A., Kataoka E., Sasaki T., Hamada K., Sasaki J., Mizuno K., Hasegawa G., Kishimoto H., Iizuka M., Naito M., Enomoto K., Watanabe S., Mak T.W., and Nakano T. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 113 (2004) 1774-1783
21. Cheng A.M., Byrom M.W., Shelton J., and Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33 (2005) 1290-1297
22. Wan X.W., Jiang M., Cao H.F., He Y.Q., Liu S.Q., Qiu X.H., Wu M.C., and Wang H.Y. The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma. J Cancer Res Clin Oncol 129 (2003) 100-106
23. Hu T.H., Huang C.C., Lin P.R., Chang H.W., Ger L.P., Lin Y.W., Changchien C.S., Lee C.M., and Tai M.H. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97 (2003) 1929-1940
24. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., and Yamada K.M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280 (1998) 1614-1617
25. Itoh S., Maeda T., Shimada M., Aishima S., Shirabe K., Tanaka S., and Maehara Y. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res 10 (2004) 2812-2817
26. Fujii T., Koshikawa K., Nomoto S., Okochi O., Kaneko T., Inoue S., Yatabe Y., Takeda S., and Nakao A. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J Hepatol 41 (2004) 104-111
27. Yamamoto H., Itoh F., Adachi Y., Sakamoto H., Adachi M., Hinoda Y., and Imai K. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 112 (1997) 1290-1296
28. Arii S., Mise M., Harada T., Furutani M., Ishigami S., Niwano M., Mizumoto M., Fukumoto M., and Imamura M. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 24 (1996) 316-322
29. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., and Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (2005) 685-689
30. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., and Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3 (2006) 87-98